Erythrocyte membrane Na+,K+-ATPase and Mg 2+-ATPaSe activities in subjects with methylenetetrahydrofolate reductase (MTHFR) 677 C→T genotype and moderate hyperhomocysteinaemia. The role of L-phenylalanine and L-alanine

Clinical Chemistry and Laboratory Medicine

Volumn 44, Issue 4, 2006, Pages 423-427

  Schulpis, Kleopatra H ^a   Giannoulia Karantana, Aglaia ^a   Papaconstantinou, Evangelos D ^a   Parthimos, Theodore ^b   Tjamouranis, Ioanna ^a   Tsakiris, Stylianos ^b  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Erythrocyte membrane; Hyperhomocysteinaemia; L alanine; L phenylalanine; Na+,K + ATPase

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADENOSINE TRIPHOSPHATASE (MAGNESIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM); ALANINE; ANTIOXIDANT; CYANOCOBALAMIN; FOLIC ACID; PHENYLALANINE; SODIUM ION;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ERYTHROCYTE MEMBRANE; EVALUATION; FOLIC ACID BLOOD LEVEL; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERHOMOCYSTEINEMIA; INCUBATION TIME; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION; SPECTROPHOTOMETRY; STATISTICAL SIGNIFICANCE; VITAMIN SUPPLEMENTATION;

ADENOSINE TRIPHOSPHATASES; ADULT; ALANINE; ANTIOXIDANTS; CASE-CONTROL STUDIES; CELL-FREE SYSTEM; CELLS, CULTURED; ERYTHROCYTE MEMBRANE; GENOTYPE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NA(+)-K(+)-EXCHANGING ATPASE; PHENYLALANINE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33645783026     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2006.069     Document Type: Article

References (31)

1. Delvin EE, Rozen R, Merouani A, Genest J, Lambert M. Influence of methylenetetrahydrofolate reductase genotype, age, vitamin B-12, and folate status on plasma homocysteine in children. Am J Clin Nutr 2000;72:1469-73.
2. Papoutsakis C, Yiannakouris N, Manios Y, Papakonstantinou E, Magkos F, Schulpis KH, et al. Plasma homocysteine concentrations in Greek children are influenced by an interaction between the methylenetetrahydrofolate reductase C677T genotype and folate status. J Nutr 2005;135:383-8.
3. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.
4. Matthews RG, Sheppard C, Goulding C. Methylenetetrahydrofolate reductase and methionine synthase: biochemistry and molecular biology. Eur J Pediatr 1998;157(Suppl 2):S54-9.
5. Visy JM, Le Coz P, Chadefaux B, Fressinaud C, Woimant F, Marquet J, et al. Homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency revealed by stroke in adult siblings. Neurology 1991;41:1313-5.
6. Sweadner KJ, Goldin SM. Active transport of sodium and potassium ions: mechanisms, function, and regulation. N Engl J Med 1980;302:777-83.
7. +)-ATPase activity in galactive-fed mice. Implications for polyol pathway and diabetic neuropathy. Diabetes 1990;36:663-6.
8. Sanui H, Rubin H. The role of magnesium in cell proliferation and transformation. In: Boynton AL, MacKeehan WL, Whitfield JP, editors. Ions, cell proliferation and cancer. New York: Academic Press, 1982:517-37.
9. +-ATPase activity by the metabolites accumulating in homocystinuria. Metab Brain Dis 2002;17:83-91.
10. +-ATPase activity by homocysteine is probably mediated by oxidative stress. Neurochem Res 2001;26:1195-200.
11. +)-ATPase activity caused by homocysteine. Int J Dev Neurosci 2002;20:77-81.
12. 2+-ATPaSe activities and biogenie amine concentration in phenylketonuria. Clin Biochem 2002;35:281-5.
13. +-ATPase by lithium. Med Sci Res 1987;15:697-8.
14. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987;422:43-52.
15. Schneede J, Refsum H, Ueland PM. Biological and environmental determinants of plasma homocysteine. Semin Thromb Hemost 2000;26:263-79.
16. Saiki PK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, et al. Primer-directed enzymatic application of DNA with a thermostable DNA polymerase. Science 1988;239:487-91.
17. Schulpis KH, Tsakiris S, Karikas GA, Moukas M, Behrakis P. Effect of diet on plasma total antioxidant status in phenylketonuric patients. Eur J Clin Nutr 2003;57:383-7.
18. Strube M, Haenen GR, Van den Berg H, Bast A. Pitfalls in a method for assessment of total antioxidant capacity. Free Radic Res 1997;26:515-21.
19. Galbraith DA, Watts DC. Changes in some cytoplasmic enzymes from red cells fractionated into age groups by centrifugation in Ficoll/Triosil gradients. Comparison of normal humans and patients with Duchenne muscular dystrophy. Biochem J 1980;191:63-70.
20. Kamber E, Poyiagi A, Deliconstantinos G. Modifications in the activities of membrane-bound enzymes during in vivo ageing of human and rabbit erythrocytes. Comp Biochem Physiol 1984;77:95-9.
21. Lowry OH, Rosebrough NJ, Farr AL, Randal RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
22. Bowler K, Tirri R. The temperature characteristics of synaptic membrane ATPases from immature and adult rat brain. J Neurochem 1974;23:611-3.
23. Lees GJ. Contributory mechanisms in the causation of neurodegenerative disorders. Neuroscience 1993;54:287-322.
24. Welch GN, Upchurch G Jr, Loscalzo I. Homocysteine, oxidative stress and vascular disease. Hosp Pract 1997;32:81-2, 85, 88-92.
25. Cipolla MJ, Williamson WK, Nehler ML, Taylor LM, Porter JM. The effect of elevated homocysteine levels on adrenergic vasoconstriction of human resistance arteries: the role of the endothelium and reactive oxygen species. J Vasc Surg 2000;31:751-9.
26. Engbersen AM, Franken DG, Boers GH, Stevens EM, Trijbels FJ, Bloom HJ. Thermolabile, 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 1995;56:142-50.
27. Atmaca G. Antioxidant effects of sulfur-containing amino acids. Yonsei Med J 2004;45:776-88.
28. Cuttormsen AB, Ueland PM, Nesthus I, Nygard O, Schneede J, Vollset SE, et al. Determinants and vitamin responsiveness of intermediate hyperhomocysteine (≥40 micromol/liter). The Hordaland Homocysteine study. J Clin Invest 1996;98:2174-83.
29. Malinow MR. Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis. Circulation 1990;81:2004-6.
30. Chevillard C, Cardenas ML, Cornish-Bowden A. The competition plot: a simple test of whether two reactions occur at the same active site. J Biochem 1993;289:599-604.
31. Erecinska M, Silver IA. Ions and energy in mammalian brain. Prog Neurobiol 1994;16:37-71.